Company Amarillo Biosciences, Inc. Other OTC
Equities
AMAR
US02301P2056
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Point-of-care Testing
100.0
%
| 4 | 100.0 % | 0 | 100.0 % | -96.53% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 4 | 100.0 % | 0 | 100.0 % | -96.53% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chun Hsien Tsai
CEO | Chief Executive Officer | 54 | 21-04-14 |
Lawrence Lin
COO | Chief Operating Officer | 55 | 21-07-31 |
Shu Ying Pan
SAM | Sales & Marketing | - | - |
Chih-Heng Lu
PRN | Corporate Officer/Principal | 44 | 21-08-10 |
Junyong Lee
LAW | General Counsel | 54 | 21-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yao Chung Chiang
BRD | Director/Board Member | 70 | 21-04-14 |
Pao Sheng Wei
BRD | Director/Board Member | 66 | 22-06-14 |
Chung Yi Tsai
BRD | Director/Board Member | 47 | 21-04-14 |
Chung Jung Tsai
BRD | Director/Board Member | 52 | 21-04-14 |
Ting Chuan Lee
BRD | Director/Board Member | 40 | 21-04-14 |
Wen Han Chang
BRD | Director/Board Member | 60 | 21-04-14 |
Chun Hsien Tsai
CEO | Chief Executive Officer | 54 | 21-04-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,144,506 | 2,857,736 ( 46.51 %) | 0 | 46.51 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+9.42% | 115B | |
+11.84% | 106B | |
-2.68% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |